The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Spanish biotechnology company Cocuus has raised €2.5 million in a pre-Series A funding round, as it looks to scale up its 3D bioprinting technology for the production of alternative proteins. The round was led by Big Idea Ventures, Cargill Ventures, Eatable Adventures and Tech Transfer UPV. Cocuus plans to use the capital to scale up its business and expand into other international markets. Cocuus founder and CEO, Patxi Larumbe, said: "We are very proud to have attracted the interest of international investors with this round of financing. Thanks to this capital injection, we will be able to bring our technology within reach of corporations that want to print proteins on an industrial scale." Big Idea Ventures founder and managing general partner, Andrew D Ive, added: “At Big Idea Ventures, we invest in technology which impacts the alternative protein industry’s entire value chain. Cocuus’ technology addresses a major pain point of structured plant- and cell-based meat production methods: scalability."